Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EndoSign® Cell collection device (ES-CYT-102)

K-Number: K233142 · 2024-01-19

ApplicantCyted Limited
Decision Date2024-01-19
Product CodeEOX
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

EndoSign® Cell collection device (ES-CYT-102) is a medical device manufactured by Cyted Limited. It received FDA 510(k) clearance on 2024-01-19 under approval number K233142. The device is classified under product code EOX. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EndoSign® Cell collection device (ES-CYT-102)?

EndoSign® Cell collection device (ES-CYT-102) is a medical device that received FDA 510(k) clearance on 2024-01-19. It is manufactured by Cyted Limited. The 510(k) number is K233142.

When was EndoSign® Cell collection device (ES-CYT-102) approved by the FDA?

EndoSign® Cell collection device (ES-CYT-102) received FDA 510(k) clearance on 2024-01-19, under approval number K233142.

What company makes EndoSign® Cell collection device (ES-CYT-102)?

EndoSign® Cell collection device (ES-CYT-102) is manufactured by Cyted Limited.

What is the FDA product code for EndoSign® Cell collection device (ES-CYT-102)?

The FDA product code for EndoSign® Cell collection device (ES-CYT-102) is EOX.

Related Clinical Trials

Related Devices (Code: EOX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.